Body Project SMIL: Prevention of Eating Disorders Among Young Women With Psychiatric Illness With the Body Project
Launched by AARHUS UNIVERSITY HOSPITAL · Mar 18, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Body Project SMIL is a clinical trial designed to help prevent eating disorders in young women aged 15-25 who have body dissatisfaction and a diagnosed psychiatric illness, such as anxiety or mood disorders. This trial is testing a virtual program called the Body Project, which is led by peers and consists of four one-hour online sessions. The aim is to help participants challenge harmful beauty standards and promote a healthier body image. Participants will be randomly placed in either the Body Project group or a writing group that focuses on body image for four weeks.
To join the study, participants must be comfortable with online discussions and should not currently have a clinically diagnosed eating disorder. Participants will have their experiences measured before and after the program, and again at six months, one year, and two years later. The goal is to see if this program can effectively reduce body dissatisfaction and the risk of developing eating disorders. It's important to know that while this program offers support, it does not replace professional treatment for those with active eating disorders. Parental consent is needed for those under 18, and anyone can withdraw from the study at any time without any consequences. For more information, you can visit the study's website at www.bodyproject.dk.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • self-reported body dissatisfaction and a medically verified psychiatric diagnosis (e.g., mood disorders, anxiety disorders, ADHD, and personality disorders)
- Exclusion Criteria:
- • ED symptoms equivalent to clinically significant ED corresponding to a diagnostic level according to DSM-5 criteria as evaluated via the Eating Disorder Diagnostic Interview.
- • Acute psychiatric instability or psychosis or suicide attempt within the last 12 months, or inability to cognitively understand the project or work in the online group setting either due to illness or severe substance abuse.
- • Not speaking and understanding Danish.
About Aarhus University Hospital
Aarhus University Hospital is a leading research institution in Denmark, dedicated to advancing medical science and improving patient care through innovative clinical trials. As a key sponsor of clinical research, the hospital integrates cutting-edge technology and multidisciplinary expertise to conduct studies that address critical health challenges. With a commitment to ethical standards and patient safety, Aarhus University Hospital collaborates with a diverse network of academic and industry partners, ensuring that its research initiatives contribute to the global body of medical knowledge and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Patients applied
Trial Officials
Loa Clausen, PhD
Principal Investigator
Aarhus University Hospital Psychiatry
Caroline B Abild, Cl. dietician
Study Director
Aarhus University Hospital Psychiatry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported